Jednak pamitaj o tym, e stosujesz go na wasn rk
So obesity treatments will be at the top of medical priorities now. Throughout the discussion, Dr Lavanya emphasised careful patient selection: So you have to choose the right patient, and the patient has to decide: when to start, how long to continue, and when to stop
For IBS-D (diarrhea-predominant), common after COVID infection, options include: Rifaximin (550mg three times daily for 14 days) shows moderate evidence of efficacy, with retreatment possible for recurrent symptoms
One study evaluating comorbidities and diabetic complications in patients with NL found high rates of smoking, hypertension, hyperlipidemia, obesity, coronary artery disease, myocardial infarction, thyroid disease, poor kidney function, and poor glucose control (56A)
Twenty-five serious side effects were reported in 18 participants from the placebo arm and seven participants in the treatment arm, most of which were unlikely to be treatment-related
